Neofordex (Dexamethasone)

Dexamethasone, the active ingredient in Neofordex, is a glucocorticoid presented as an oral dosage form for systemic use. It is employed to reduce inflammation and modify immune responses in a range of conditions, including autoimmune disorders, allergic reactions, certain cancers, and adrenal insufficiency. GNH USA supplies Neofordex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Neofordex, a glucocorticoid, acts on inflammatory and immune pathways to provide therapeutic benefit across several disease groups.

Inflammatory and autoimmune disorders: reduces inflammation and suppresses aberrant immune activity. Allergic reactions: mitigates severe hypersensitivity responses. Certain cancers (as part of chemotherapy regimens): helps control tumor‑related inflammation and edema. Adrenal insufficiency (replacement therapy): provides necessary glucocorticoid activity when endogenous production is inadequate.

Neofordex may cause a range of adverse reactions, from mild to severe, depending on dose and duration of therapy.

Common Side Effects: - Increased appetite and weight gain. - Insomnia or sleep disturbances. - Mild gastrointestinal discomfort such as nausea. - Fluid retention causing mild swelling.

Serious or Rare Side Effects: - Severe infections due to immunosuppression. - Adrenal insufficiency on abrupt discontinuation. - Hyperglycemia or worsening of diabetes. - Psychiatric disturbances including mood swings or psychosis. - Osteoporosis with long‑term use.

Before initiating Neofordex, clinicians should evaluate several safety considerations.

Assess for active infection: avoid use in uncontrolled infections. Monitor blood glucose: adjust antidiabetic therapy as needed. Use the lowest effective dose: limit duration to reduce risk of systemic effects. Avoid abrupt discontinuation: taper gradually to prevent adrenal crisis. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Neofordex can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Potent CYP3A4 inhibitors (e.g., ketoconazole): may increase dexamethasone exposure and toxicity. - Live vaccines: immunosuppression can reduce vaccine effectiveness and increase infection risk.

Moderate Interactions (Monitor Closely): - NSAIDs: combined use raises risk of gastrointestinal ulceration or bleeding. - Antidiabetic agents: dexamethasone may raise blood glucose, requiring dose adjustments. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, necessitating INR monitoring.